📍 WASHINGTON D.C., USA
02.11.2026
Administrative Law Showdown Looms Over Drug Approvals Based on Compromised Data
The unfolding dispute surrounding the FDA's attempt to strip market authorization from the vasculitis medication Tavneos represents a watershed moment for American administrative and pharmaceutical jurisprudence. The fed...